Andrea McNeill
Wellington Management Company
16 Papers
71 Citations
Andrea McNeill is an academic researcher from Wellington Management Company. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 5, co-authored 9 publications.
Chat about Author
Papers
Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.
Q. Sue Huang,Tim Wood,Lauren Jelley,Tineke Jennings,Sarah Jefferies,Karen Daniells,Annette Nesdale,Tony Dowell,Nikki Turner,Priscilla Campbell-Stokes,Michelle Balm,Hazel C Dobinson,Cameron C. Grant,Shelley James,Nayyereh Aminisani,Jacqui Ralston,Wendy Gunn,Judy Bocacao,Jessica Danielewicz,Tessa Moncrieff,Andrea McNeill,Liza Lopez,Ben Waite,Tomasz Kiedrzynski,Hannah Schrader,Rebekah Gray,Kayla Cook,Danielle Currin,Chaune Engelbrecht,Whitney Tapurau,Leigh Emmerton,Maxine Martin,Michael G Baker,Susan S. Taylor,Adrian Trenholme,Conroy Wong,Shirley Lawrence,Colin McArthur,Alicia Stanley,Sally Roberts,Fahimeh Rahnama,Jenny Bennett,Chris Mansell,Meik Dilcher,Anja M. Werno,Jennifer Grant,Antje van der Linden,Ben Youngblood,Paul G. Thomas,Richard J. Webby +49 more
TL;DR: The use of nonpharmaceutical interventions such as lockdowns and border closures is not currently recommended for pandemic influenza control New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave using multiple surveillance systems, and observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020.
COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study.
Sarah Jefferies,Nigel P. French,Charlotte Gilkison,Giles Graham,Virginia Hope,Jonathan C. Marshall,Caroline McElnay,Andrea McNeill,Petra Muellner,Shevaun Paine,Namrata Prasad,Julia Scott,Jillian Sherwood,Liang Yang,Patricia Priest +14 more
TL;DR: New Zealand's response resulted in low relative burden of disease, low levels of population disease disparities, and the initial achievement of COVID-19 elimination, with few disparities and increasing coverage of females, Māori, Pacific peoples, and lower socioeconomic groups.
298
Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand
Q. Sue Huang,Tim Wood,Lauren Jelley,Tineke Jennings,Sarah Jefferies,Karen Daniells,Annette Nesdale,Tony Dowell,Nikki Turner,Priscilla Campbell-Stokes,Michelle Balm,Hazel C Dobinson,Cameron C. Grant,Shelley James,Nayyereh Aminisani,Jacqui Ralston,Wendy Gunn,Judy Bocacao,Jessica Danielewicz,Tessa Moncrieff,Andrea McNeill,Liza Lopez,Ben Waite,Tomasz Kiedrzynski,Hannah Schrader,Rebekah Gray,Kayla Cook,Danielle Currin,Chaune Engelbrecht,Whitney Tapurau,Leigh Emmerton,Maxine Martin,Michael G Baker,Susan Taylor,Adrian Trenholme,Conroy Wong,Shirley Lawrence,Colin McArthur,Alicia Stanley,Sally Roberts,Fahimeh Ranama,Jenny Bennett,Chris Mansell,Meik Dilcher,Anja M. Werno,Jennifer Grant,Antje van der Linden,Ben Youngblood,Paul G. Thomas,Richard J. Webby +49 more
TL;DR: Using multiple surveillance systems, this finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.
111
Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing.
Tara Swadi,Jemma L. Geoghegan,Tom Devine,Caroline McElnay,Jillian Sherwood,Phil Shoemack,Xiaoyun Ren,Matt Storey,Sarah Jefferies,Erasmus Smit,James Hadfield,Aoife Kenny,Lauren Jelley,Andrew Sporle,Andrea McNeill,G. Edwin Reynolds,Kip Mouldey,Lindsay Lowe,Gerard J.B. Sonder,Alexei J. Drummond,Sue Huang,David Welch,Edward C. Holmes,Nigel P. French,Colin R Simpson,Joep de Ligt +25 more
TL;DR: In this paper, a flight from Dubai, United Arab Emirates, that arrived in New Zealand on September 29, 2019, test results were positive for 7 persons in MIQ and all 7 SARS-CoV-2 genomes were genetically identical, except for a single mutation in 1 sample.
69
Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border
Jordan Douglas,Dave Winter,Andrea McNeill,Samantha Carr,Michael Bunce,Nigel P. French,James Hadfield,Joep de Ligt,David Welch,Jemma L. Geoghegan +9 more
TL;DR: In the second quarter of 2022, there was a global surge of emergent SARS-CoV-2 lineages that had a distinct growth advantage over then-dominant Omicron BA.1 and BA.2 as discussed by the authors .